Boston Scientific Corp (BSX) income statement
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.64+0.61 (+1.42%)
Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –
Boston Scientific Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 69.9%
- Operating margin
- 19.8%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 1.24
- Debt to equity
- 0.51
- Debt to assets
- 27.9%
- Cash to current liabilities
- 8.4%
Valuation
- P/E ratio
- 17.7
- Price to sales
- 3.01
- Price to book
- 2.54
- Dividend yield
- –
See a number that looks wrong?